Effect of eugenol against streptococcus agalactiae and synergistic interaction with biologically produced silver nanoparticles

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Perugini Biasi Garbin, Renata ^a   Saori Otaguiri, Eliane ^a   Morey, Alexandre Tadachi ^a   Fernandes Da Silva, Mayara ^a   Belotto Morguette, Ana Elisa ^a   Armando Contreras Lancheros, César ^a   Kian, Danielle ^a   Perugini, Márcia Regina Eches ^a   Nakazato, Gerson ^a   Durán, Nelson ^b   Nakamura, Celso Vataru ^c   Yamauchi, Lucy Megumi ^a   Yamada Ogatta, Sueli Fumie ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Departamento de Ciências Básicas da Saúde Centro de Ciências da Saúde Jardim Universitário   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EUGENOL; SILVER NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; BIOFILM; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SCANNING TRANSMISSION ELECTRON MICROSCOPY; STREPTOCOCCUS AGALACTIAE;

EID: 84928485423     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/861497     Document Type: Article

References (46)

1. A. Schuchat, "Epidemiology of group B streptococcal disease in the United States: shifting paradigms, " Clinical Microbiology Reviews, vol. 11, no. 3, pp. 497-513, 1998.
2. T. H. Skoff, M. M. Farley, S. Petit et al., "Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007, " Clinical Infectious Diseases, vol. 49, no. 1, pp. 85-92, 2009.
3. P. Melin, "Neonatal group B streptococcal disease: from pathogenesis to preventive strategies, " Clinical Microbiology and Infection, vol. 17, no. 9, pp. 1294-1303, 2011.
4. J. R. Verani, L. McGee, and S. J. Schrag, "Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010, "Morbidity and Mortality Weekly Report, vol. 59, no. RR-10, pp. 1-36, 2010.
5. J. K. Palmeiro, L. M. Dalla-Costa, S. E. Fracalanzza et al., "Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil, " Journal of ClinicalMicrobiology, vol. 48, no. 12, pp. 4397-4403, 2010.
6. S. M. Garland, E. Cottrill, L. Markowski et al., "Antimicrobial resistance in group B streptococcus: the Australian experience, " Journal of Medical Microbiology, vol. 60, part 2, pp. 230-235, 2011.
7. C. Turner, P. Turner, L. Po et al., "Group B streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on theThai-Myanmar border, " BMC Infectious Diseases, vol. 12, article 34, 2012.
8. J. Longtin, C. Vermeiren, D. Shahinas et al., "Novelmutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy, " Antimicrobial Agents and Chemotherapy, vol. 55, no. 6, pp. 2983-2985, 2011.
9. N. Nagano, Y. Nagano, M. Toyama et al., "Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1, " Journal of Antimicrobial Chemotherapy, vol. 67, no. 4, Article ID dkr546, pp. 849-856, 2012.
10. A. Lambiase, A. Agangi, M. Del Pezzo et al., "In vitro resistance to macrolides and clindamycin by group B streptococcus isolated from pregnant and nonpregnant women, " Infectious Diseases in Obstetrics and Gynecology, vol. 2012, Article ID 913603, 5 pages, 2012.
11. E. S. Otaguiri, A. E. B. Morguette, E. R. Tavares et al., "Commensal Streptococcus agalactiae isolated from patients seen atUniversityHospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants, "BMCMicrobiology, vol. 13, no. 1, article 297, 2013.
12. S. Fröhlicher, G. Reichen, M. Müller et al., "Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre, " Swiss MedicalWeekly, vol. 144, Article IDw13935, 2014.
13. M. J. Alves, I. C. F. R. Ferreira, A. Martins, and M. Pintado, "Antimicrobial activity of wild mushroom extracts against clinical isolates resistant to different antibiotics, " Journal of Applied Microbiology, vol. 113, no. 2, pp. 466-475, 2012.
14. A. Elaissi, Z. Rouis, N. A. B. Salem et al., "Chemical composition of 8 eucalyptus species' essential oils and the evaluation of their antibacterial, antifungal and antiviral activities, " BMC Complementary and Alternative Medicine, vol. 12, article 81, 2012.
15. F. O. Ruíz, G. Gerbaldo, M. J. García, W. Giordano, L. Pascual, and I. L. Barberis, "Synergistic effect between two bacteriocinlike inhibitory substances produced by lactobacilli strains with inhibitory activity for Streptococcus agalactiae, " Current Microbiology, vol. 64, no. 4, pp. 349-356, 2012.
16. C. V. Nakamura, T. Ueda-Nakamura, E. Bando, A. F. Negrão Melo, D. A. Garcia Cortez, and B. P. Dias Filho Filho, "Antibacterial activity ofOcimum gratissimumL. essential oil, " Memorias do Instituto Oswaldo Cruz, vol. 94, no. 5, pp. 675-678, 1999.
17. K. P. Devi, S. A. Nisha, R. Sakthivel, and S. K. Pandian, "Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane, " Journal of Ethnopharmacology, vol. 130, no. 1, pp. 107-115, 2010.
18. K. P. Devi, R. Sakthivel, S. A. Nisha, N. Suganthy, and S. K. Pandian, "Eugenol alters the integrity of cellmembrane and acts against the nosocomial pathogen Proteus mirabilis, " Archives of Pharmacal Research, vol. 36, no. 3, pp. 282-292, 2013.
19. S. B. de Paula, T. F. Bartelli, V. Di Raimo et al., "Effect of eugenol on cell surface hydrophobicity, adhesion, and biofilm of Candida tropicalis and Candida dubliniensis isolated from oral cavity of HIV-infected patients, " Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 505204, 8 pages, 2014.
20. J.-P. Dai, X.-F. Zhao, J. Zeng et al., "Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza A virus activity, " PLoS ONE, vol. 8, no. 4, Article ID e61026, 2013.
21. T. Ueda-Nakamura, R. R. Mendonça-Filho, J. A. Morgado-Díaz et al., "Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum, " Parasitology International, vol. 55, no. 2, pp. 99-105, 2006.
22. I. Gülçin, "Antioxidant activity of eugenol: a structure-activity relationship study, " Journal of Medicinal Food, vol. 14, no. 9, pp. 975-985, 2011.
23. S. K. Jaganathan and E. Supriyanto, "Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells, " Molecules, vol. 17, no. 6, pp. 6290-6304, 2012.
24. A. N. Daniel, S. M. Sartoretto, G. Schmidt, S. M. Caparroz-Assef, C. A. Bersani-Amado, and R. K. N. Cuman, "Anti-inflammatory and antinociceptive activities of eugenol essential oil in experimental animal models, " Revista Brasileira de Farmacognosia, vol. 19, no. 1, pp. 212-217, 2009.
25. N. Durán, P. D. Marcato, R. de Conti, O. L. Alves, F. T. M. Costa, and M. Brocchi, "Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action, " Journal of the Brazilian Chemical Society, vol. 21, no. 6, pp. 949-959, 2010.
26. A. Herman and A. P. Herman, "Nanoparticles as antimicrobial agents: their toxicity and mechanisms of action, " Journal of Nanoscience and Nanotechnology, vol. 14, no. 1, pp. 946-957, 2014.
27. A. M. Allahverdiyev, K. V. Kon, E. S. Abamor, M. Bagirova, and M. Rafailovich, "Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents, " Expert Review of Anti-Infective Therapy, vol. 9, no. 11, pp. 1035-1052, 2011.
28. V. F. Cardozo, A. G. Oliveira, E. K. Nishio et al., "Antibacterial activity of extracellular compounds produced by a Pseudomonas strain againstmethicillin-resistant Staphylococcus aureus (MRSA) strains, " Annals of Clinical Microbiology and Antimicrobials, vol. 12, article 12, 2013.
29. I. N. Ghosh, S. D. Patil, T. K. Sharma, S. K. Srivastava, R. Pathania, and N. K. Navani, "Synergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applications, " International Journal of Nanomedicine, vol. 8, pp. 4721-4731, 2013.
30. N. Durán, P. D. Marcato, O. L. Alves, G. I. H. de Souza, and E. Esposito, "Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains, " Journal of Nanobiotechnology, vol. 3, article 8, 2005.
31. Clinical and Laboratory Standards Institute (CLSI), "Clinical and Laboratory Standards Institute: performance standards for antimicrobial susceptibility testing; twentieth informational supplement, " Document M100-S22, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2012.
32. J. Kwiecínski, S. Eick, and K. Wójcik, "Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase, " International Journal of Antimicrobial Agents, vol. 33, no. 4, pp. 343-347, 2009.
33. S. Borges, J. Silva, and P. Teixeira, "Survival and biofilm formation by Group B streptococci in simulated vaginal fluid at different pHs, " Antonie van Leeuwenhoek, vol. 101, no. 3, pp. 677-682, 2012.
34. R. M. B. Shafreen, S. Srinivasan, P. Manisankar, and S. K. Pandian, "Biofilm formation by Streptococcus pyogenes:modulation of exopolysaccharide by fluoroquinolone derivatives, " Journal of Bioscience and Bioengineering, vol. 112, no. 4, pp. 345-350, 2011.
35. M. K. Yadav, S. W. Park, S. W. Chae, J. J. Song, and H. C. Kim, "Antimicrobial activities of Eugenia caryophyllata extract and its major chemical constituent eugenol against Streptococcus pneumoniae, " Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 121, no. 12, pp. 1198-1206, 2013.
36. G. P. Kamatou, I. Vermaak, and A. M. Viljoen, "Eugenol-from the remote Maluku Islands to the international market place: a review of a remarkable and versatile molecule, " Molecules, vol. 17, no. 6, pp. 6953-6981, 2012.
37. S. Ananda Baskaran, G. W. Kazmer, L. Hinckley, S. M. Andrew, and K. Venkitanarayanan, "Antibacterial effect of plant-derived antimicrobials on major bacterial mastitis pathogens in vitro, " Journal of Dairy Science, vol. 92, no. 4, pp. 1423-1429, 2009.
38. S. O. Oyedemi, A. I. Okoh, L. V. Mabinya, G. Pirochenva, and A. J. Afolayan, "The proposed mechanism of bactericidal action of eugenol, α-terpineol and γ-terpinene against Listeria monocytogenes, Streptococcus pyogenes, Proteus vulgaris and Escherichia coli, " African Journal of Biotechnology, vol. 8, no. 7, pp. 1280-1286, 2009.
39. J.-S. Xu, Y. Li, X. Cao, and Y. Cui, "The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats, " Experimental and Therapeutic Medicine, vol. 5, no. 6, pp. 1667-1670, 2013.
40. A. O. Gill and R. A. Holley, "Inhibition of membrane bound ATPases of Escherichia coli and Listeria monocytogenes by plant oil aromatics, " International Journal of Food Microbiology, vol. 111, no. 2, pp. 170-174, 2006.
41. J. A. Otter, K. Vickery, J. T. Walker et al., "Surface-attached cells, biofilms and biocide susceptibility: implications for hospital cleaning and disinfection, " Journal of Hospital Infection, vol. 89, no. 1, pp. 16-27, 2015.
42. M. Otto, "Physical stress and bacterial colonization, " FEMS Microbiology Reviews, vol. 38, no. 6, pp. 1250-1270, 2014.
43. A. Nostro, R. Scaffaro, M. D'Arrigo et al., "Development and characterization of essential oil component-based polymer films: a potential approach to reduce bacterial biofilm, " Applied Microbiology and Biotechnology, vol. 97, no. 21, pp. 9515-9523, 2013.
44. M. Adil, K. Singh, P. K. Verma, and A. U. Khan, "Eugenolinduced suppression of biofilm-forming genes in Streptococcus mutans: an approach to inhibit biofilms, " Journal of Global Antimicrobial Resistance, vol. 2, no. 4, pp. 286-292, 2014.
45. P. Mitsch, K. Zitterl-Eglseer, B. Köhler, C. Gabler, R. Losa, and I. Zimpernik, "The effect of two different blends of essential oil components on the proliferation of Clostridium perfringens in the intestines of broiler chickens, " Poultry Science, vol. 83, no. 4, pp. 669-675, 2004.
46. F. Sosto and C. Benvenuti, "Controlled study on thymol + eugenol vaginal douche versus econazole in vaginal candidiasis and metronidazole in bacterial vaginosis, " Arzneimittel-Forschung, vol. 61, no. 2, pp. 126-131, 2011.